ANTIKÖRPERMOLEKÜLE MIT SPEZIFITÄT FÜR HUMANES IL-6
European patent · EP1960430 · In force
Register entry
- Publication number
- EP1960430
- Application number
- EP06820403
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 4, 2006
- Published
- Aug 27, 2008
- Granted
- Sep 24, 2014
- Protection ends at the latest
- Dec 3, 2026
- Next annual fee due
- Dec 31, 2026
- IPC classes
- C07K 16/24 (2006.01)
- Priority
- US 748926 P 09.12.2005
- PCT application
- PCT/GB2006/004518 04.12.2006
- PCT publication
- WO2007/066082 14.06.2007
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Feb 14, 2022
Transferred
- Owner
- UCB Pharma S.A., Allée de la Recherche 60, 1070 Bruxelles, Belgium → R-Pharm International, LLC, 19, bld.1, Berzarina street, first floor, premise V, room 9,, Moscow, 123154, Russian Federation
Published in Swissreg on 14.02.2022
- Apr 6, 2017
Licensee entered
- License holder
- R-Pharm, CJSC (Closed Joint Stock Company), 19 1 bld Berzarina Street, 123154 Moscow, Russian Federation
Published in Swissreg on 06.04.2017
- Nov 29, 2014
Agent entered
- Representative
- Hepp Wenger Ryffel AG, Friedtalweg 5, 9500 Wil / SG
Published in Swissreg on 29.11.2014
- Sep 24, 2014
Granted
Published in Swissreg on 24.09.2014
Parties
Inventor
Slough Berkshire SL1 3WE, GB
Slough Berkshire SL1 3WE, GB
Slough Berkshire SL1 3WE, GB
Slough Berkshire SL1 3WE, GB
Slough Berkshire SL1 3WE, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.